APO Research

APO RESEARCH · REPORT

Human Serum and Plasma

Selected research

Industry Growth & Trends

Global Human Serum and Plasma Industry Growth and Trends Forecast to 2032

Market perspective

The global Human Serum and Plasma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Serum and Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Serum and Plasma include Thermo Fisher, Merck Millipore, Baxter, Zen-Bio, Trina Bioreactives, TCS Biosciences Ltd, SeraCare, Monobind and Cytiva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Serum and Plasma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Serum and Plasma market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Serum and Plasma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Serum and Plasma.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Serum and Plasma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Serum and Plasma Market by Company

Thermo Fisher

Merck Millipore

Baxter

Zen-Bio

Trina Bioreactives

TCS Biosciences Ltd

SeraCare

Monobind

Cytiva

Akron

Human Serum and Plasma Segment by Type

Fresh Human Serum and Plasma

Frozen Human Serum and Plasma

Human Serum and Plasma Segment by Application

Vaccines and Antibodies

Cell Culture

In Vitro Diagnostics

Clinical Research

Others

Human Serum and Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum and Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Serum and Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Serum and Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Serum and Plasma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Serum and Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fresh Human Serum and Plasma Table 2. Major Company of Frozen Human Serum and Plasma Table 3. Global Human Serum and Plasma Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Serum and Plasma Sales by Type (2021-2026) & (Units) Table 5. Global Human Serum and Plasma Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Serum and Plasma Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Serum and Plasma Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Serum and Plasma Price by Type (2021-2026) & (US$/Unit) Table 9. Global Human Serum and Plasma Sales by Type (2027-2032) & (Units) Table 10. Global Human Serum and Plasma Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Serum and Plasma Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Serum and Plasma Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Serum and Plasma Price by Type (2027-2032) & (US$/Unit) Table 14. North America Human Serum and Plasma Sales by Type (2021-2026) & (Units) Table 15. North America Human Serum and Plasma Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Serum and Plasma Sales by Type (2021-2026) & (Units) Table 17. Europe Human Serum and Plasma Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Serum and Plasma Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Human Serum and Plasma Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Serum and Plasma Sales by Type (2021-2026) & (Units) Table 21. Latin America Human Serum and Plasma Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Serum and Plasma Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Human Serum and Plasma Sales by Type (2021-2026) & (US$ Million) Table 24. Human Serum and Plasma Industry Trends Table 25. Human Serum and Plasma Industry Drivers Table 26. Human Serum and Plasma Industry Opportunities and Challenges Table 27. Human Serum and Plasma Industry Restraints Table 28. Global Human Serum and Plasma Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Serum and Plasma Revenue Market Share by Company (2021-2026) Table 30. Global Human Serum and Plasma Sales by Company (2021-2026) & (Units) Table 31. Global Human Serum and Plasma Sales Share by Company (2021-2026) Table 32. Global Human Serum and Plasma Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Human Serum and Plasma Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Serum and Plasma Major Company Production Sites and Headquarters Table 35. Global Human Serum and Plasma Company, Product Type & Application Table 36. Global Human Serum and Plasma Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Serum and Plasma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Serum and Plasma Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Serum and Plasma Sales by Region (2021-2026) & (Units) Table 41. Global Human Serum and Plasma Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Serum and Plasma Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Serum and Plasma Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Human Serum and Plasma Sales by Region (2027-2032) & (Units) Table 46. Global Human Serum and Plasma Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Serum and Plasma Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Serum and Plasma Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Serum and Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Human Serum and Plasma Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Serum and Plasma Sales by Application (2021-2026) & (Units) Table 52. Global Human Serum and Plasma Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Serum and Plasma Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Serum and Plasma Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Serum and Plasma Price by Application (2021-2026) & (US$/Unit) Table 56. Global Human Serum and Plasma Sales by Application (2027-2032) & (Units) Table 57. Global Human Serum and Plasma Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Serum and Plasma Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Serum and Plasma Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Serum and Plasma Price by Application (2027-2032) & (US$/Unit) Table 61. North America Human Serum and Plasma Sales by Application (2021-2026) & (Units) Table 62. North America Human Serum and Plasma Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Serum and Plasma Sales by Application (2021-2026) & (Units) Table 64. Europe Human Serum and Plasma Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Serum and Plasma Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Human Serum and Plasma Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Serum and Plasma Sales by Application (2021-2026) & (Units) Table 68. Latin America Human Serum and Plasma Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Serum and Plasma Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Human Serum and Plasma Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Company Information Table 72. Thermo Fisher Business Overview Table 73. Thermo Fisher Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Thermo Fisher Human Serum and Plasma Product Portfolio Table 75. Thermo Fisher Recent Development Table 76. Merck Millipore Company Information Table 77. Merck Millipore Business Overview Table 78. Merck Millipore Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Millipore Human Serum and Plasma Product Portfolio Table 80. Merck Millipore Recent Development Table 81. Baxter Company Information Table 82. Baxter Business Overview Table 83. Baxter Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Baxter Human Serum and Plasma Product Portfolio Table 85. Baxter Recent Development Table 86. Zen-Bio Company Information Table 87. Zen-Bio Business Overview Table 88. Zen-Bio Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Zen-Bio Human Serum and Plasma Product Portfolio Table 90. Zen-Bio Recent Development Table 91. Trina Bioreactives Company Information Table 92. Trina Bioreactives Business Overview Table 93. Trina Bioreactives Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Trina Bioreactives Human Serum and Plasma Product Portfolio Table 95. Trina Bioreactives Recent Development Table 96. TCS Biosciences Ltd Company Information Table 97. TCS Biosciences Ltd Business Overview Table 98. TCS Biosciences Ltd Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. TCS Biosciences Ltd Human Serum and Plasma Product Portfolio Table 100. TCS Biosciences Ltd Recent Development Table 101. SeraCare Company Information Table 102. SeraCare Business Overview Table 103. SeraCare Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. SeraCare Human Serum and Plasma Product Portfolio Table 105. SeraCare Recent Development Table 106. Monobind Company Information Table 107. Monobind Business Overview Table 108. Monobind Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Monobind Human Serum and Plasma Product Portfolio Table 110. Monobind Recent Development Table 111. Cytiva Company Information Table 112. Cytiva Business Overview Table 113. Cytiva Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Cytiva Human Serum and Plasma Product Portfolio Table 115. Cytiva Recent Development Table 116. Akron Company Information Table 117. Akron Business Overview Table 118. Akron Human Serum and Plasma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Akron Human Serum and Plasma Product Portfolio Table 120. Akron Recent Development Table 121. North America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 122. North America Human Serum and Plasma Sales by Country (2021-2026) & (Units) Table 123. North America Human Serum and Plasma Sales Market Share by Country (2021-2026) Table 124. North America Human Serum and Plasma Sales Forecast by Country (2027-2032) & (Units) Table 125. North America Human Serum and Plasma Sales Market Share Forecast by Country (2027-2032) Table 126. North America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Human Serum and Plasma Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Human Serum and Plasma Market Share by Country (2021-2026) Table 129. North America Human Serum and Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Human Serum and Plasma Market Share Forecast by Country (2027-2032) Table 131. Europe Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 132. Europe Human Serum and Plasma Sales by Country (2021-2026) & (Units) Table 133. Europe Human Serum and Plasma Sales Market Share by Country (2021-2026) Table 134. Europe Human Serum and Plasma Sales Forecast by Country (2027-2032) & (Units) Table 135. Europe Human Serum and Plasma Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Human Serum and Plasma Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Human Serum and Plasma Market Share by Country (2021-2026) Table 139. Europe Human Serum and Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Human Serum and Plasma Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Human Serum and Plasma Sales by Country (2021-2026) & (Units) Table 143. Asia-Pacific Human Serum and Plasma Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Human Serum and Plasma Sales Forecast by Country (2027-2032) & (Units) Table 145. Asia-Pacific Human Serum and Plasma Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Human Serum and Plasma Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Human Serum and Plasma Market Share by Country (2021-2026) Table 149. Asia-Pacific Human Serum and Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Human Serum and Plasma Market Share Forecast by Country (2027-2032) Table 151. Latin America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 152. Latin America Human Serum and Plasma Sales by Country (2021-2026) & (Units) Table 153. Latin America Human Serum and Plasma Sales Market Share by Country (2021-2026) Table 154. Latin America Human Serum and Plasma Sales Forecast by Country (2027-2032) & (Units) Table 155. Latin America Human Serum and Plasma Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Human Serum and Plasma Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Human Serum and Plasma Market Share by Country (2021-2026) Table 159. Latin America Human Serum and Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Human Serum and Plasma Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Human Serum and Plasma Sales by Country (2021-2026) & (Units) Table 163. Middle East and Africa Human Serum and Plasma Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Human Serum and Plasma Sales Forecast by Country (2027-2032) & (Units) Table 165. Middle East and Africa Human Serum and Plasma Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Human Serum and Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Human Serum and Plasma Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Human Serum and Plasma Market Share by Country (2021-2026) Table 169. Middle East and Africa Human Serum and Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Human Serum and Plasma Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Human Serum and Plasma Distributors List Table 174. Human Serum and Plasma Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Human Serum and Plasma Image Figure 2. Global Human Serum and Plasma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Serum and Plasma Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Serum and Plasma Sales (2021-2032) & (Units) Figure 5. Fresh Human Serum and Plasma Image Figure 6. Global Fresh Human Serum and Plasma Sales YoY Growth (2021-2032) & (Units) Figure 7. Frozen Human Serum and Plasma Image Figure 8. Global Frozen Human Serum and Plasma Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Human Serum and Plasma Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Serum and Plasma Market Share by Type 2025 VS 2032 Figure 11. North America Human Serum and Plasma Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Serum and Plasma Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Serum and Plasma Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Serum and Plasma Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Serum and Plasma Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Serum and Plasma Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Serum and Plasma Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Serum and Plasma Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Serum and Plasma Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Serum and Plasma Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Serum and Plasma Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Vaccines and Antibodies Image Figure 24. Global Vaccines and Antibodies Sales YoY Growth (2021-2032) & (Units) Figure 25. Cell Culture Image Figure 26. Global Cell Culture Sales YoY Growth (2021-2032) & (Units) Figure 27. In Vitro Diagnostics Image Figure 28. Global In Vitro Diagnostics Sales YoY Growth (2021-2032) & (Units) Figure 29. Clinical Research Image Figure 30. Global Clinical Research Sales YoY Growth (2021-2032) & (Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 33. Global Human Serum and Plasma Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Serum and Plasma Market Share by Application 2025 VS 2032 Figure 35. North America Human Serum and Plasma Sales Market Share in Volume by Application in 2025 Figure 36. North America Human Serum and Plasma Sales Market Share in Value by Application in 2025 Figure 37. Europe Human Serum and Plasma Sales Market Share in Volume by Application in 2025 Figure 38. Europe Human Serum and Plasma Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Human Serum and Plasma Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Human Serum and Plasma Sales Market Share in Value by Application in 2025 Figure 41. Latin America Human Serum and Plasma Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Human Serum and Plasma Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Human Serum and Plasma Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Human Serum and Plasma Sales Market Share in Value by Application in 2025 Figure 45. North America Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. North America Human Serum and Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Human Serum and Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Human Serum and Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Europe Human Serum and Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Serum and Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Serum and Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Asia-Pacific Human Serum and Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Serum and Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Human Serum and Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Latin America Human Serum and Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Serum and Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Human Serum and Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Serum and Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 62. Middle East and Africa Human Serum and Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Serum and Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Human Serum and Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Serum and Plasma Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Human Serum and Plasma Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fresh Human Serum and Plasma
  • Frozen Human Serum and Plasma
Applications
  • Vaccines and Antibodies
  • Cell Culture
  • In Vitro Diagnostics
  • Clinical Research
  • Others
Companies covered
  • Thermo Fisher
  • Merck Millipore
  • Baxter
  • Zen-Bio
  • Trina Bioreactives
  • TCS Biosciences Ltd
  • SeraCare
  • Monobind
  • Cytiva
  • Akron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Serum and Plasma Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Serum and Plasma Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Serum and Plasma Market by Type
  6. 1.3.1 Fresh Human Serum and Plasma
  7. 1.3.2 Frozen Human Serum and Plasma
  8. 1.4 Global Human Serum and Plasma Market Size by Type
  9. 1.4.1 Global Human Serum and Plasma Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Serum and Plasma Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Serum and Plasma Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Serum and Plasma Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Serum and Plasma Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Serum and Plasma Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Serum and Plasma Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Serum and Plasma Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Serum and Plasma Industry Trends
  2. 2.2 Human Serum and Plasma Industry Drivers
  3. 2.3 Human Serum and Plasma Industry Opportunities and Challenges
  4. 2.4 Human Serum and Plasma Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Serum and Plasma Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Serum and Plasma Sales (2021-2026)
  3. 3.3 Global Top Players by Human Serum and Plasma Price (2021-2026)
  4. 3.4 Global Human Serum and Plasma Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Serum and Plasma Major Company Production Sites & Headquarters
  6. 3.6 Global Human Serum and Plasma Company, Product Type & Application
  7. 3.7 Global Human Serum and Plasma Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Serum and Plasma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Serum and Plasma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Serum and Plasma Tier 1, Tier 2, and Tier 3
4 Human Serum and Plasma Regional Status and Outlook
  1. 4.1 Global Human Serum and Plasma Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Serum and Plasma Historic Market Size by Region
  3. 4.2.1 Global Human Serum and Plasma Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Serum and Plasma Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Serum and Plasma Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Serum and Plasma Forecasted Market Size by Region
  7. 4.3.1 Global Human Serum and Plasma Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Serum and Plasma Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Serum and Plasma Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Serum and Plasma by Application
  1. 5.1 Human Serum and Plasma Market by Application
  2. 5.1.1 Vaccines and Antibodies
  3. 5.1.2 Cell Culture
  4. 5.1.3 In Vitro Diagnostics
  5. 5.1.4 Clinical Research
  6. 5.1.5 Others
  7. 5.2 Global Human Serum and Plasma Market Size by Application
  8. 5.2.1 Global Human Serum and Plasma Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Human Serum and Plasma Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Human Serum and Plasma Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Human Serum and Plasma Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Human Serum and Plasma Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Human Serum and Plasma Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Human Serum and Plasma Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Human Serum and Plasma Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher
  2. 6.1.1 Thermo Fisher Company Information
  3. 6.1.2 Thermo Fisher Business Overview
  4. 6.1.3 Thermo Fisher Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Human Serum and Plasma Product Portfolio
  6. 6.1.5 Thermo Fisher Recent Developments
  7. 6.2 Merck Millipore
  8. 6.2.1 Merck Millipore Company Information
  9. 6.2.2 Merck Millipore Business Overview
  10. 6.2.3 Merck Millipore Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Millipore Human Serum and Plasma Product Portfolio
  12. 6.2.5 Merck Millipore Recent Developments
  13. 6.3 Baxter
  14. 6.3.1 Baxter Company Information
  15. 6.3.2 Baxter Business Overview
  16. 6.3.3 Baxter Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter Human Serum and Plasma Product Portfolio
  18. 6.3.5 Baxter Recent Developments
  19. 6.4 Zen-Bio
  20. 6.4.1 Zen-Bio Company Information
  21. 6.4.2 Zen-Bio Business Overview
  22. 6.4.3 Zen-Bio Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zen-Bio Human Serum and Plasma Product Portfolio
  24. 6.4.5 Zen-Bio Recent Developments
  25. 6.5 Trina Bioreactives
  26. 6.5.1 Trina Bioreactives Company Information
  27. 6.5.2 Trina Bioreactives Business Overview
  28. 6.5.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Trina Bioreactives Human Serum and Plasma Product Portfolio
  30. 6.5.5 Trina Bioreactives Recent Developments
  31. 6.6 TCS Biosciences Ltd
  32. 6.6.1 TCS Biosciences Ltd Company Information
  33. 6.6.2 TCS Biosciences Ltd Business Overview
  34. 6.6.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 TCS Biosciences Ltd Human Serum and Plasma Product Portfolio
  36. 6.6.5 TCS Biosciences Ltd Recent Developments
  37. 6.7 SeraCare
  38. 6.7.1 SeraCare Company Information
  39. 6.7.2 SeraCare Business Overview
  40. 6.7.3 SeraCare Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SeraCare Human Serum and Plasma Product Portfolio
  42. 6.7.5 SeraCare Recent Developments
  43. 6.8 Monobind
  44. 6.8.1 Monobind Company Information
  45. 6.8.2 Monobind Business Overview
  46. 6.8.3 Monobind Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Monobind Human Serum and Plasma Product Portfolio
  48. 6.8.5 Monobind Recent Developments
  49. 6.9 Cytiva
  50. 6.9.1 Cytiva Company Information
  51. 6.9.2 Cytiva Business Overview
  52. 6.9.3 Cytiva Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cytiva Human Serum and Plasma Product Portfolio
  54. 6.9.5 Cytiva Recent Developments
  55. 6.10 Akron
  56. 6.10.1 Akron Company Information
  57. 6.10.2 Akron Business Overview
  58. 6.10.3 Akron Human Serum and Plasma Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Akron Human Serum and Plasma Product Portfolio
  60. 6.10.5 Akron Recent Developments
7 North America by Country
  1. 7.1 North America Human Serum and Plasma Sales by Country
  2. 7.1.1 North America Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Serum and Plasma Sales by Country (2021-2026)
  4. 7.1.3 North America Human Serum and Plasma Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Serum and Plasma Market Size by Country
  6. 7.2.1 North America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Serum and Plasma Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Serum and Plasma Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Serum and Plasma Sales by Country
  2. 8.1.1 Europe Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Serum and Plasma Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Serum and Plasma Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Serum and Plasma Market Size by Country
  6. 8.2.1 Europe Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Serum and Plasma Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Serum and Plasma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Serum and Plasma Sales by Country
  2. 9.1.1 Asia-Pacific Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Serum and Plasma Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Serum and Plasma Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Serum and Plasma Market Size by Country
  6. 9.2.1 Asia-Pacific Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Serum and Plasma Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Serum and Plasma Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Serum and Plasma Sales by Country
  2. 10.1.1 South America Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Serum and Plasma Sales by Country (2021-2026)
  4. 10.1.3 South America Human Serum and Plasma Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Serum and Plasma Market Size by Country
  6. 10.2.1 South America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Serum and Plasma Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Serum and Plasma Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Serum and Plasma Sales by Country
  2. 11.1.1 Middle East and Africa Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Serum and Plasma Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Serum and Plasma Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Serum and Plasma Market Size by Country
  6. 11.2.1 Middle East and Africa Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Serum and Plasma Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Serum and Plasma Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Serum and Plasma Value Chain Analysis
  2. 12.1.1 Human Serum and Plasma Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Serum and Plasma Production Mode & Process
  7. 12.2 Human Serum and Plasma Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Serum and Plasma Distributors
  10. 12.2.3 Human Serum and Plasma Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research